- Country: Ukraine
- Summary: Ibandronic Acid; Letrozole; Gefitinib; Ibandronic Acid; Everolimus; Calcium Folinate; Fulvestrant
- UAT Ref No: 125413867
- Deadline: 03 Sep 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 2302664
- Notice Type: Tender
- Document Ref. No.: UA-2025-08-29-008749-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Type of purchase: goods
DK 021: 2015: 33600000-6: Pharmaceutical products
Ibandron acid, tablets, 50 mg, letrozole tablets covered with a film sheath, 2.5 mg, hefyinib, tablets, 250 mg, ibandronic acid, concentrate for infusion solution, 1 mg/ml, 6 ml, eneorolymus, tablets, tablets, tablets. 10 mg, calcium folinate, solution for injection, 10 mg/ml, 20 ml, fulvestrant, infusion solution, 50 mg/ml (250 mg/5 ml), 5 ml, syringe, syringe - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINIbandronic Acid; Letrozole; Gefitinib; Ibandronic Acid; Everolimus; Calcium Folinate; Fulvestrant - Ukraine Tender
The DEPARTMENT OF HEALTH OF KHMELNYTSKY REGIONAL STATE ADMINISTRATION, a Government sector organization in Ukraine, has announced a new tender for Ibandronic Acid; Letrozole; Gefitinib; Ibandronic Acid; Everolimus; Calcium Folinate; Fulvestrant. This tender is published on UkraineTenders under UAT Ref No: 125413867 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-03.
The estimated tender value is UAH 2302664, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
